Arrhythmias and cardiac stimulation

• Heterogeneous Phenotype of Long QT Syndrome Caused by the KCNH2-H562R Mutation: Importance of Familial Genetic Testing

  Carmen Muñoz-Esparza, Esperanza García-Molina, Mariela Salar-Alcaraz, Pablo Peñafiel-Verdú, Juan J. Sánchez-Muñoz, Juan Martínez Sánchez, Valentín Cabañas-Perianes, Mariano Valdés Chávarri, Arcadio García Alberola, Juan R. Gimeno-Blanes

  Rev Esp Cardiol. 2015;68:861-8

• Assessment of Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Primary Health Care in Galicia, Spain: ANFAGAL Study

  Sergio Cinza-Sanjurjo, Daniel Rey-Aldana, Enrique Gestal-Pereira, Carlos Calvo-Gómez, on behalf of the investigators of the ANFAGAL (ANticoagulación en pacientes con Fibrilación Auricular en el ámbito de atención primaria de GALicia) study

  Rev Esp Cardiol. 2015;68:753-60

• Quality of Vitamin K Antagonist Anticoagulation in Spain: Prevalence of Poor Control and Associated Factors

  Manuel Anguita Sánchez, Vicente Bertomeu Martínez, Ángel Cequier Fillat, on behalf of the CALIFA study researchers

  Rev Esp Cardiol. 2015;68:761-8

• Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study

  Vivencio Barrios, Carlos Escobar, Luis Prieto, Genoveva Osorio, José Polo, José María Lobos, Diego Vargas, Nicolás García

  Rev Esp Cardiol. 2015;68:769-76

• Safety of Outpatient Implantation of the Implantable Cardioverter-defibrillator

  Tomás Datino, Ángel Miracle Blanco, Alberto Núñez García, Esteban González-Torrecilla, Felipe Atienza Fernández, Ángel Arenal Maíz, Jesús Hernández-Hernández, Pablo Ávila Alonso, Gabriel Eidelman, Francisco Fernández-Avilés

  Rev Esp Cardiol. 2015;68:579-84

• Implantable Cardioverter-defibrillator Therapy for Hypertrophic Cardiomyopathy: Usefulness in Primary and Secondary Prevention

  Axel Sarrias, Enrique Galve, Xavier Sabaté, Àngel Moya, Ignacio Anguera, Elaine Núñez, Roger Villuendas, Óscar Alcalde, David García-Dorado

  Rev Esp Cardiol. 2015;68:492-6

• Comparison of Estimated Glomerular Filtration Rate Equations for Dosing New Oral Anticoagulants in Patients With Atrial Fibrillation

  Sergio Manzano-Fernández, José M. Andreu-Cayuelas, Francisco Marín, Esteban Orenes-Piñero, Pilar Gallego, Mariano Valdés, Vicente Vicente, Gregory Y.H. Lip, Vanessa Roldán

  Rev Esp Cardiol. 2015;68:497-504

• Non-ventricular, Clinical, and Functional Features of the RyR2R420Q Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia

  Diana Domingo, Patricia Neco, Elena Fernández-Pons, Spyros Zissimopoulos, Pilar Molina, José Olagüe, M. Paz Suárez-Mier, F. Anthony Lai, Ana M. Gómez, Esther Zorio

  Rev Esp Cardiol. 2015;68:398-407

• Clinical Profile and Incidence of Ventricular Arrhythmia in Patients Undergoing Defibrillator Generator Replacement in Spain

  Adolfo Fontenla, María López Gil, José Martínez Ferrer, Javier Alzueta, Ignacio Fernández Lozano, Xavier Viñolas, Aníbal Rodríguez, Joaquín Fernández de la Concha, Ignasi Anguera, Fernando Arribas

  Rev Esp Cardiol. 2014;67:986-92

• QT Interval Heterogeneities Induced Through Local Epicardial Warming/Cooling. An Experimental Study

  Antonio Guill, Álvaro Tormos, José Millet, Eduardo J. Roses, Antonio Cebrián, Luis Such-Miquel, Luis Such, Manuel Zarzoso, Antonio Alberola, Francisco J. Chorro

  Rev Esp Cardiol. 2014;67:993-8

• Outcomes of a Contemporary Sample of Patients With Atrial Fibrillation Taking Digoxin: Results From the AFBAR Study

  Moisés Rodríguez-Mañero, Fernando Otero-Raviña, Javier García-Seara, Lucrecia Zugaza-Gurruchaga, José M. Rodríguez-García, Rubén Blanco-Rodríguez, Victorino Turrado Turrado, José M. Fernández-Villaverde, Rafael C. Vidal-Pérez, José R. González-Juanatey, on behalf of the Barbanza Group Researchers

  Rev Esp Cardiol. 2014;67:890-7

• Ventricular Arrhythmias in Super-responders to Cardiac Resynchronization Therapy

  Inés García-Lunar, Víctor Castro-Urda, Jorge Toquero-Ramos, Susana Mingo-Santos, Vanessa Moñivas-Palomero, Cristina Daniela Mitroi, Manuel Sánchez-García, Elena Pérez-Pereira, Hugo E. Delgado, Ignacio Fernández-Lozano

  Rev Esp Cardiol. 2014;67:883-9

• Association Between rs2200733 and rs7193343 Genetic Variants and Atrial Fibrillation in a Spanish Population, and Meta-analysis of Previous Studies

  Albert Ferrán, José María Alegret, Isaac Subirana, Gerard Aragonès, Carla Lluis-Ganella, César Romero-Menor, Francesc Planas, Jorge Joven, Roberto Elosua

  Rev Esp Cardiol. 2014;67:822-9

• Cryoballoon Ablation in Young Patients With Lone Paroxysmal Atrial Fibrillation

  Maciej Wójcik, Alexander Berkowitsch, Sergey Zaltsberg, Christian W. Hamm, Heinz F. Pitschner, Thomas Neumann, Malte Kuniss

  Rev Esp Cardiol. 2014;67:558-63

• The Clinical Significance of Pregnancy in Brugada Syndrome

  Moisés Rodríguez-Mañero, Rubén Casado-Arroyo, Andrea Sarkozy, Eva Leysen, Juan Antonio Sieira, Mehdi Namdar, Gulio Conte, Moisés Levinstein, Gian-Battista Chierchia, Carlo de Asmundis, Pedro Brugada

  Rev Esp Cardiol. 2014;67:176-80

• Clinical Benefit of Cardiac Resynchronization Therapy With a Defibrillator in Patients With an Ejection Fraction > 35% Estimated by Cardiac Magnetic Resonance

  Óscar Fabregat-Andrés, Pilar García-González, Alfonso Valle-Muñoz, Jordi Estornell-Erill, Leandro Pérez-Boscá, Victor Palanca-Gil, Rafael Payá-Serrano, Aurelio Quesada-Dorador, Salvador Morell, Francisco Ridocci-Soriano

  Rev Esp Cardiol. 2014;67:107-13

• Effectiveness and Safety of Remote Monitoring of Patients With an Implantable Loop Recorder

  Yasmín Drak-Hernández, Jorge Toquero-Ramos, José M. Fernández, Elena Pérez-Pereira, Víctor Castro-Urda, Ignacio Fernández-Lozano

  Rev Esp Cardiol. 2013;66:943-8

• Loss of Continuous Biventricular Pacing in Cardiac Resynchronization Therapy Patients: Incidence, Causes, and Outcomes

  Teresa Colchero, Miguel A. Arias, Fernando A. López-Sánchez, Marta Pachón, Laura Domínguez-Pérez, Alberto Puchol, Jesús Jiménez-López, María Lázaro, Virgilio Martínez-Mateo, Luis Rodríguez-Padial

  Rev Esp Cardiol. 2013;66:377-83

• Low Clinical Penetrance in Causal Mutation Carriers for Cardiac Channelopathies

  Juan Jiménez-Jáimez, Miguel Álvarez, María Algarra, Rosa Macías Ruíz, Rocío Peñas, Francisca Valverde, Gustavo Tortajada, Jose Antonio Lorente, Rafael Melgares, Luis Tercedor

  Rev Esp Cardiol. 2013;66:275-81

• Cardiac Manifestations in Myotonic Dystrophy Type 1 Patients Followed Using a Standard Protocol in a Specialized Unit

  María Facenda-Lorenzo, Julio Hernández-Afonso, Marcos Rodríguez-Esteban, Juan C. de León-Hernández, José J. Grillo-Pérez

  Rev Esp Cardiol. 2013;66:193-7